I 
119TH CONGRESS 
1ST SESSION H. R. 6561 
To amend the Public Health Service Act to provide for a public awareness 
campaign with respect to human papillomavirus, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
DECEMBER 10, 2025 
Ms. CASTOR of Florida (for herself, Mr. BACON, and Ms. SCHRIER) introduced 
the following bill; which was referred to the Committee on Energy and 
Commerce 
A BILL 
To amend the Public Health Service Act to provide for 
a public awareness campaign with respect to human 
papillomavirus, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Promoting Resources 
to Expand Vaccination, Education and New Treatments 
for HPV Cancers Act of 2025’’ or the ‘‘PREVENT HPV 
Cancers Act of 2025’’. 
SEC. 2. FINDINGS. 
Congress finds the following: 
VerDate Sep 11 2014 
07:11 Dec 11, 2025
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6561.IH
H6561
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(1) The human papillomavirus (referred to in 
this Act as ‘‘HPV’’) causes six different types of 
cancer (anal, cervical, oropharynx, penile, vaginal, 
and vulvar). 
(2) Approximately 39,300 cases of cancer are 
caused by HPV each year impacting both women 
and men. 
(3) About 91 percent of cervical and anal can-
cers are thought to be caused by HPV. 
(4) Black and Hispanic women are more likely 
to get HPV-associated cervical cancer than women 
of other races and ethnicities due to disparities in 
access to cancer screening and early detection. 
(5) New cases of cervical cancer decreased 
among women in young age groups, likely due to 
HPV vaccination, but in recent years, new cases of 
cervical cancer rates among women in older age 
groups have plateaued or, in the case of women ages 
30–34, increased. 
(6) Cervical cancer screening has declined and 
there has been an increase in cervical cancer diag-
nosed at distant stages, which are more difficult to 
treat and more likely to recur, leading to greater 
morbidity and mortality. 
VerDate Sep 11 2014 
07:11 Dec 11, 2025
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6561.IH
H6561
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(7) Approximately 70 percent of oropharyngeal 
cancer is tied to HPV, and such cancers are more 
than twice as common in men as in women. 
(8) Most HPV infections that can lead to can-
cer can be prevented by vaccines. 
(9) HPV vaccines can also help prevent recur-
rent respiratory papillomatosis, anal and genital 
warts. 
(10) Vaccination for HPV is approved for men 
and women. 
(11) The vaccines are most effective if adminis-
tered when an individual is between the ages of 9 
and 12, but the vaccines are licensed for men and 
women through age 45. 
(12) Approximately 63 percent of adolescents 
have completed the HPV vaccine series, a lower rate 
than other routine recommended vaccinations. 
(13) Adolescents living in rural areas continue 
to be less likely to have initiated and completed the 
HPV vaccine series than those living in urban areas. 
(14) Health providers’ recommendation of the 
vaccine is critical to getting adolescents vaccinated. 
VerDate Sep 11 2014 
07:11 Dec 11, 2025
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H6561.IH
H6561
kjohnson on DSK7ZCZBW3PROD with $$_JOB
SEC. 3. HPV CANCER PREVENTION PUBLIC AWARENESS 
CAMPAIGN. 
(a) IN GENERAL.—Section 317 of the Public Health 
Service Act (42 U.S.C. 247b) is amended by adding at 
the end the following new subsection: 
‘‘(o) HPV CANCER PREVENTION PUBLIC AWARE-
NESS CAMPAIGN.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall carry out a national 
campaign to— 
‘‘(A) increase awareness of the importance 
of HPV vaccination for preventing HPV-associ-
ated cancers; 
‘‘(B) combat misinformation about HPV 
vaccination; and 
‘‘(C) increase HPV vaccination rates and 
completion of the vaccine series. 
‘‘(2) CONSULTATION.—In carrying out the na-
tional campaign required by paragraph (1), the Sec-
retary shall consult with the National Academy of 
Medicine, including health care providers and public 
health associations, nonprofit organizations (includ-
ing those that represent communities most impacted 
by HPV-associated cancers and communities with 
low vaccination rates), State and local public health 
VerDate Sep 11 2014 
07:11 Dec 11, 2025
Jkt 069200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H6561.IH
H6561
kjohnson on DSK7ZCZBW3PROD with $$_JOB
departments, elementary and secondary education 
organizations (including student and parent organi-
zations), and institutions of higher education, to so-
licit advice on evidence-based information for policy 
development and program development, implementa-
tion, and evaluation. 
‘‘(3) REQUIREMENTS.—The national campaign 
required by paragraph (1) shall— 
‘‘(A) include the use of evidence-based 
media and public engagement; 
‘‘(B) be carried out through competitive 
grants or cooperative agreements awarded to 1 
or more nonprofit entities with a history devel-
oping and implementing similar campaigns; 
‘‘(C) include the development of culturally 
and linguistically competent resources that shall 
be tailored for— 
‘‘(i) communities with high rates of— 
‘‘(I) unvaccinated individuals, in-
cluding males; 
‘‘(II) individuals with high rates 
of cervical cancer and other HPV-as-
sociated cancers (such as Black and 
Hispanic women); and 
VerDate Sep 11 2014 
07:11 Dec 11, 2025
Jkt 069200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H6561.IH
H6561
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘(III) populations impacted by 
the increase in oropharynx cancers, 
including active-duty service members 
and veterans; 
‘‘(ii) rural communities; and 
‘‘(iii) such other communities as the 
Secretary determines appropriate; 
‘‘(D) include the dissemination of HPV 
vaccination information and communication re-
sources to health care providers and health care 
facilities (including primary care providers, 
community health centers, dentists, obstetri-
cians, and gynecologists), and such providers 
and such facilities for pediatric care, State and 
local public health departments, elementary and 
secondary schools, and colleges and universities; 
‘‘(E) be complementary to, and coordi-
nated with, any other Federal efforts with re-
spect to— 
‘‘(i) HPV vaccination; and 
‘‘(ii) screening for HPV-associated 
cancers, including self-collection methods; 
‘‘(F) include message testing to identify 
culturally competent and effective messages for 
behavioral change; and 
VerDate Sep 11 2014 
07:11 Dec 11, 2025
Jkt 069200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H6561.IH
H6561
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘(G) include the award of grants or coop-
erative agreements to State, local, and Tribal 
public health departments— 
‘‘(i) to engage with communities speci-
fied in subparagraph (C), local education 
agencies, health care providers, community 
organizations, or other groups the Sec-
retary determines are appropriate to de-
velop and deliver effective strategies to in-
crease HPV vaccination rates; and 
‘‘(ii) to disseminate culturally and lin-
guistically competent resources on the Na-
tional Breast and Cervical Cancer Early 
Detection Program and where an indi-
vidual can access the screenings locally. 
‘‘(4) OPTIONS FOR DISSEMINATION OF INFOR-
MATION.—The national campaign required by para-
graph (1) may— 
‘‘(A) include the use of— 
‘‘(i) social media, television, radio, 
print, the internet, and other media; 
‘‘(ii) in person or virtual public com-
munications; and 
‘‘(iii) recognized, trusted figures; 
VerDate Sep 11 2014 
07:11 Dec 11, 2025
Jkt 069200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H6561.IH
H6561
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘(B) be targeted to specific groups and 
communities specified in paragraph (3)(C); and 
‘‘(C) include the dissemination of informa-
tion highlighting each of the following: 
‘‘(i) Recommended age range to get 
the HPV vaccine. 
‘‘(ii) The benefits of getting vac-
cinated against HPV, including the poten-
tial to not acquire HPV-associated cancers. 
‘‘(iii) HPV vaccine safety and the sys-
tems in place to monitor such safety. 
‘‘(5) AUTHORIZATION
OF
APPROPRIATIONS.— 
There is authorized to be appropriated to carry out 
this subsection $5,000,000 for each of fiscal years 
2026 through 2030.’’. 
(b) REPORT TO CONGRESS.—Not later than Sep-
tember 30, 2027, the Secretary of Health and Human 
Services shall submit to the Committee on Energy and 
Commerce of the House of Representatives and the Com-
mittee on Health, Education, Labor and Pensions of the 
Senate a report— 
(1) that contains a qualitative assessment of 
the campaign under subsection (o) of section 317 of 
the Public Health Service Act (42 U.S.C. 247b), as 
VerDate Sep 11 2014 
07:11 Dec 11, 2025
Jkt 069200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H6561.IH
H6561
kjohnson on DSK7ZCZBW3PROD with $$_JOB
added by subsection (a), and the activities conducted 
under such campaign; and 
(2) on, with respect to the impact on cancer as-
sociated with human papillomavirus, the activities 
conducted under such subsection (o). 
SEC. 4. BREAST AND CERVICAL CANCER EARLY DETECTION 
PROGRAM. 
(a) IN GENERAL.—Section 1510(a) of the Public 
Health Service Act (42 U.S.C. 300n–5(a)) is amended by 
striking ‘‘and $275,000,000 for fiscal year 2012’’ and in-
serting ‘‘$275,000,000 for fiscal year 2012, and 
$300,000,000 for each fiscal years 2026 through 2030’’. 
(b) COORDINATING COMMITTEE.—Section 1501(d) of 
the Public Health Service Act (42 U.S.C. 300k(d)) is 
amended— 
(1) in the subsection heading, by striking 
‘‘2020’’ and inserting ‘‘2030’’; and 
(2) by striking ‘‘2020’’ and inserting ‘‘2030’’. 
Æ 
VerDate Sep 11 2014 
07:11 Dec 11, 2025
Jkt 069200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6301
E:\BILLS\H6561.IH
H6561
kjohnson on DSK7ZCZBW3PROD with $$_JOB